Blaich G, Göttlicher M, Cikryt P, Metzler M
Institute of Pharmacology and Toxicology, University of Würzburg, F.R.G.
J Steroid Biochem. 1990 Feb;35(2):201-4. doi: 10.1016/0022-4731(90)90275-w.
In order to elucidate the role of metabolic activation of the synthetic estrogen, diethylstilbestrol (DES), in the mechanism of liver tumor formation in male Syrian golden hamsters observed after combined treatment with DES and 7,8-benzoflavone (7,8-BF), the metabolism of DES and the concentrations and activities of various drug-metabolizing enzymes were studied in hamster liver microsomes after various pretreatments. The levels of the hepatic aromatic hydrocarbon (Ah) receptor were also determined. Pretreatment with 7,8-BF increased both P450 and cytochrome b5 levels, whereas phenobarbital (PB) and 3-methylcholanthrene (MC) induced P450 but not cytochrome b5. 7,8-BF pretreatment increased 7-ethoxyresorufin-O-deethylase (EROD) 3-fold and 7-pentoxyresorufin-O-dealkylase (PROD) 2.5-fold, whereas aromatic hydrocarbon hydroxylase (AHH) and 7-ethoxycoumarin-O-deethylase (ECOD) activities were only slightly induced by 7,8-BF. MC pretreatment increased EROD 8-fold and PROD activity 7-fold, whereas PB pretreatment enhanced AHH 4.5-fold and PROD activity 4-fold. In contrast to PB, pretreatment with 7,8-BF and MC reduced the oxidative metabolism of DES in hepatic microsomes, but the pattern of metabolites was identical with that in untreated controls. Treatment of hamsters with the inducers changed the hepatic Ah receptor level. PB and MC-pretreatment resulted in an increase of the receptor level 1.5-fold and 1.3-fold, respectively, whereas 7,8-BF-pretreatment leads to a 1.5-fold decrease. The dissociation constant Kd is 170 nM for the reaction of 7,8-BF with the hamster Ah receptor compared to 70 nM for 5,6-BF and 38 nM for 2,3,7,8-tetrachlorodibenzofuran (TCDF). The Kd-value is 3.6 nM for TCDF with the rat receptor protein. It is concluded from these data that metabolic activation of DES is not involved in the mechanism of hepatocarcinogenesis in this animal tumor model.
为了阐明合成雌激素己烯雌酚(DES)的代谢活化在与DES和7,8 - 苯并黄酮(7,8 - BF)联合处理后观察到的雄性叙利亚金仓鼠肝脏肿瘤形成机制中的作用,在经过各种预处理后,研究了仓鼠肝脏微粒体中DES的代谢以及各种药物代谢酶的浓度和活性。还测定了肝脏芳烃(Ah)受体的水平。用7,8 - BF预处理可增加P450和细胞色素b5的水平,而苯巴比妥(PB)和3 - 甲基胆蒽(MC)诱导P450但不诱导细胞色素b5。7,8 - BF预处理使7 - 乙氧基异吩恶唑酮 - O - 脱乙基酶(EROD)增加3倍,7 - 戊氧基异吩恶唑酮 - O - 脱烷基酶(PROD)增加2.5倍,而芳烃羟化酶(AHH)和7 - 乙氧基香豆素 - O - 脱乙基酶(ECOD)活性仅被7,8 - BF轻微诱导。MC预处理使EROD增加8倍,PROD活性增加7倍,而PB预处理使AHH增加4.5倍,PROD活性增加4倍。与PB相反,用7,8 - BF和MC预处理降低了肝脏微粒体中DES的氧化代谢,但代谢物模式与未处理对照相同。用诱导剂处理仓鼠改变了肝脏Ah受体水平。PB和MC预处理分别导致受体水平增加1.5倍和1.3倍,而7,8 - BF预处理导致受体水平降低1.5倍。7,8 - BF与仓鼠Ah受体反应的解离常数Kd为170 nM,而5,6 - BF为70 nM,2,3,7,8 - 四氯二苯并呋喃(TCDF)为38 nM。TCDF与大鼠受体蛋白的Kd值为3.6 nM。从这些数据得出结论,在这个动物肿瘤模型中,DES的代谢活化不参与肝癌发生机制。